New rare genetic variants are linked to ALS, expanding understanding of genetic contributors. About a quarter of ALS cases have an identifiable genetic contributor. Findings support broader use of ...
Every few months for the past three years, Jeff Vierstra has been receiving infusions in his spine that target and disable a ...
Columbia's Silence ALS program is testing spinal antisense therapy in a high‑risk patient; early EMG tests normalized.
Morning Overview on MSN
Scientist with rare ALS mutation seeks experimental treatment option
A scientist diagnosed with an ultra-rare form of ALS linked to a CHCHD10 gene mutation is now enrolled in a one-of-a-kind ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results